Fred Strohmeier Promoted to Agilent Senior VP and President of Life Sciences and Diagnostics Group
Agilent Technologies (California, USA) has announced the promotion of Fred Strohmeier, vice president and general manager of Agilent's Life Science Products and Solutions, to senior vice president, Agilent, and president of Agilent's Life Sciences and Diagnostics Group (LDG), effective immediately.
Agilent Technologies (California, USA) has announced the promotion of Fred Strohmeier, vice president and general manager of Agilent's Life Science Products and Solutions, to senior vice president, Agilent, and president of Agilent's Life Sciences and Diagnostics Group (LDG), effective immediately.
The announcement follows the planned separation of the companies into two independently publicly traded companies in September 2013. Strohmeir has worked for Agilent for 34 years and is based in Waldbronn, Germany, where he has been country president and managing director for Agilent Technologies Deutschland GmbH.
William (Bill) Sullivan, Agilent president and CEO, said: “Fred is an excellent choice to lead this fast-growing business segment. He is a highly respected leader with a wealth of deep experience and expertise in life sciences products and solutions — the foundation for LDG. Fred was an integral part of the formation of the new LDG, and I look forward to his leadership of the group.”
For further information visit www.agilent.com
.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
